Latest News - IDEXX Laboratories
Top Corporates Hub
IDEXX Laboratories
Is This the Right Time to Hold EW Stock in Your Portfolio?
22.10.2026 11:48
Edwards Lifesciences' TMTT and TAVR growth, strong clinical evidence and solid balance sheet support expansion, but tariffs and currency headwinds threaten margins.
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
22.10.2026 11:45
Illumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placements and innovations despite persistent weakness in research markets.
IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued?
21.10.2026 05:18
IDEXX Laboratories (IDXX) drew fresh attention after Jefferies reiterated its Buy rating while cutting two animal health peers on pricing concerns, and highlighted diagnostics as relatively better insulated within the broader veterinary and livestock market. Recent trading has shifted in IDEXX Laboratories' favor, with a 7 day share price return of 5.47% and a 30 day share price gain of 8.27%. However, the year to date share price return is down 16.73% and the 1 year total shareholder return...
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
20.10.2026 15:10
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What iShares U.S. Medical Devices ETF (IHI) Sold: Abbott Leads on Friday
20.10.2026 11:04
The $3.40 billion fund sold $340.3 million of stock, cutting all 48 positions and adding none.
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
12.10.2026 07:54
Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.
Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating
12.10.2026 07:18
Keybanc analyst Steve Dechert initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Sector Weight rating.
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
30.09.2026 13:00
Chicago Pacific Founders ("CPF") today announced the exit of its investment in CoVetAI Inc. ("CoVet") following the company's acquisition by IDEXX Laboratories, Inc. (NASDAQ: IDXX). Financial terms were not disclosed.
Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis
24.09.2026 10:19
The companion animal diagnostics market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, registering an 8.7% CAGR. Growth is driven by rising pet healthcare spending, preventive care, chronic and infectious diseases, and advances in AI, molecular diagnostics, point-of-care testing and automated analyzers. Molecular diagnostics will record the fastest growth, while consumables remain the leading product segment. Asia Pacific is expected to be the fastest-growing reg
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
20.09.2026 15:02
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare Conference, while reaffirming confidence in its long-term growth framework despite continued pressure
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
20.09.2026 14:02
IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product innovation, commercial investments and recurring-revenue economics as key drivers. Chief Executive Of
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide
18.09.2026 03:15
IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven software ambitions are pulling investor attention back to a simple issue: what are those cash flows worth today? Over the past 5 years the stock has delivered a decline of 25.8%, which puts the focus squarely on whether the cash flow outlook still supports...
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide
18.09.2026 03:15
IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven software ambitions are pulling investor attention back to a simple issue: what are those cash flows worth today? Over the past 5 years the stock has delivered a decline of 25.8%, which puts the focus squarely on whether the cash flow outlook still supports...
Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?
17.09.2026 11:11
IDEXX Laboratories recently expanded its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm detection, broadening routine intestinal parasite screening to seven clinically relevant parasite groups and triggering automatic, complimentary Echinococcus RealPCR follow-up tests for positive cases. This expansion deepens the clinical scope and perceived value of Faecal Dx, which has already been used in more than 50 million tests globally since 2012, potentially...
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
17.09.2026 07:00
WESTBROOK, Maine, September 17, 2026--IDEXX expands Faecal Dx™ antigen testing platform in the United Kingdom with taeniid tapeworm detection for broader intestinal parasite screening.
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
16.09.2026 11:00
WESTBROOK, Maine, September 16, 2026--IDEXX announces acquisition of CoVetAI to advance veterinary workflow intelligence.
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
16.09.2026 11:00
WESTBROOK, Maine, September 16, 2026--IDEXX announces acquisition of CoVetAI to advance veterinary workflow intelligence.
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
10.09.2026 11:20
Kingsley exercised options at $114.17 per share before immediately selling at $532.08, capturing a significant gain. His direct stake remains at 9,568 shares worth $5.12 million.
Baron Partners Fund Q2 2026 Contributors And Detractors
10.09.2026 10:15
Top contributors include Space Exploration Technologies, Tesla, Red Rock Resorts, Hyatt Hotels and Birkenstock Holding. Read more here.